|Bid||0.1500 x 400000|
|Ask||0.1550 x 1960600|
|Day's range||0.1500 - 0.1550|
|52-week range||0.1000 - 0.3050|
|Beta (5Y monthly)||0.98|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Prescient Therapeutics Limited ( ASX:PTX ) shareholders might be concerned after seeing the share price drop 27% in the...
Under the guidance of CEO Steven Yatomi-Clarke, Prescient Therapeutics Limited ( ASX:PTX ) has performed reasonably...
We can readily understand why investors are attracted to unprofitable companies. By way of example, Prescient...